Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.
D000328:Adult; D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004064:Digestive System / Q000382:microbiology*; D005260:Female; D006089:Gram-Negative Anaerobic Bacteria / Q000187:drug effects; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000517:prevention & control*; D015003:Yeasts / Q000187:drug effects
D000900:Anti-Bacterial Agents